Innovative R&D Platform for Chinese Medicine Intelligent Rehabilitation Equipment for Elderly Musculoskeletal Diseases

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300073622

Enrollment

Unknown

Registered

2023-07-17

Start date

2023-09-01

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis of knee

Interventions

Experimental group:Diagnosis using accurate multi-node distributed intelligent feedback surface electromyography, clear knee osteoarthritis lesions muscles, and then targeted intervention massage inte

Control group :Adoption of traditional tuina diagnostic and therapeutic methods. Tui na treatment of knee osteoarthritis was developed with reference to the textbook of the fifth edition of Tui na The

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of osteoarthritis of the knee; (2) Age between 50-80 years old; (3) Patients with mild-to-moderate disease classification on the WOMAC(iii) Patients with mild to moderate WOMAC classification (i.e., the sum of the scores of items (1), (2) and (3) of the WOMAC scale is less than 48); (iv) Patients who have not used analgesic medicines within 3 days. (4) No use of analgesics, Chinese medicines that warm heat and dissipate cold, remove paralysis and relieve pain, and other Chinese and Western medical treatments for osteoarthritis or osteoarthritis of the knee within 3 days.osteoarthritis or osteoarthritis of the knee joint; (5) Participate voluntarily in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Acute meniscus, peripheral ligament rupture injury, rheumatism, rheumatoid arthritis, peripheral knee joint tumor, tuberculosis, idiopathic osteonecrosis of the knee joint Tumor, tuberculosis, idiopathic osteonecrosis of the knee; (2) Combined with serious cardiovascular, pulmonary, hepatic, renal and hematopoietic diseases, hemophilia and other bleeding disorders, mental illness, pregnancy, lactating women; (3) Those who use cardiac pacemakers.

Design outcomes

Primary

Measure	Time frame
WOMAC pain Subscale;WOMAC stiffness ;WOMAC functional Subscale;	—

Secondary

Measure	Time frame
Evaluation of the electromyography data;	—

Countries

China

Contacts

Public ContactMin Fang

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine

fm-tn0510@shutcm.edu.cn+86 21 2025 6070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026